Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/307% below fair value
$3.38−0.03 (-0.88%)
Close on Nov 13, 2026Market cap $1.25BP/E 19.9Yield –
Cronos cash
Cash and short-term investments held at the end of each period.
Cronos's cash was $741.17M at Sep 30, 2026. For fiscal 2025 it was $831.79M, down 3.1% from the year before. The highest annual figure on record is $1.51B in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $831.79M | -3.1% |
| FY2024 | Dec 31, 2024 | $858.81M | -0.3% |
| FY2023 | Dec 31, 2023 | $861.53M | -1.8% |
| FY2022 | Dec 31, 2022 | $877.72M | -12.6% |
| FY2021 | Dec 31, 2021 | $1.00B | -22.1% |
| FY2020 | Dec 31, 2020 | $1.29B | -14.4% |
| FY2019 | Dec 31, 2019 | $1.51B | +6194.3% |
| FY2018 | Dec 31, 2018 | $23.93M | +226.6% |
| FY2017 | Dec 31, 2017 | $7.33M | +184.1% |
| FY2016 | Dec 31, 2016 | $2.58M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $741.17M | -10.1% |
| Q2 FY2026 | Jun 30, 2026 | $797.02M | -4.5% |
| Q1 FY2026 | Mar 31, 2026 | $821.86M | -1.9% |
| Q4 FY2025 | Dec 31, 2025 | $831.79M | -3.1% |
| Q3 FY2025 | Sep 30, 2025 | $824.17M | -4.4% |
| Q2 FY2025 | Jun 30, 2025 | $834.42M | -1.6% |
| Q1 FY2025 | Mar 31, 2025 | $837.82M | -2.0% |
| Q4 FY2024 | Dec 31, 2024 | $858.81M | -0.3% |
| Q3 FY2024 | Sep 30, 2024 | $862.03M | +2.7% |
| Q2 FY2024 | Jun 30, 2024 | $848.19M | +0.9% |
| Q1 FY2024 | Mar 31, 2024 | $855.11M | +2.2% |
| Q4 FY2023 | Dec 31, 2023 | $861.53M | -1.8% |
| Q3 FY2023 | Sep 30, 2023 | $839.56M | -5.5% |
| Q2 FY2023 | Jun 30, 2023 | $840.94M | -11.0% |
| Q1 FY2023 | Mar 31, 2023 | $836.43M | -14.8% |
| Q4 FY2022 | Dec 31, 2022 | $877.72M | -12.6% |
| Q3 FY2022 | Sep 30, 2022 | $888.75M | -14.5% |
| Q2 FY2022 | Jun 30, 2022 | $944.90M | -13.9% |
| Q1 FY2022 | Mar 31, 2022 | $981.47M | -20.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.00B | -22.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.04B | -20.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.10B | -17.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.24B | -7.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.29B | -14.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.30B | +16.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.32B | +9.7% |
| Q1 FY2020 | Mar 31, 2020 | $1.33B | -26.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.51B | +6194.3% |
| Q3 FY2019 | Sep 30, 2019 | $1.11B | +15113.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.21B | +46682.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.81B | – |
| Q4 FY2018 | Dec 31, 2018 | $23.93M | – |
| Q4 FY2017 | Dec 31, 2017 | $7.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.58M | – |
See a number that looks wrong?